Accelerating the valorisation of the BEAT inflammation technology, a microbiome-based biotherapeutic for chronic respiratory inflammatory diseases.

A nanobody-based anti-inflammatory treatment against pathogen-induced chronic lung inflammation

A nanobody-based anti-inflammatory treatment against Pseudomonas aeruginosa-induced inflammation in chronic lung diseases.

A nanobody-based anti-inflammatory treatment against Pseudomonas aeruginosa-induced inflammation in chronic lung diseases

Designing anti-inflammatory probiotics to treat chronic lung inflammation.

Exploring the anti-virulence potential of the lung microbiome in chronic airway infections

Fund Alphonse & Jean Forton and the Belgian CF Association muco.be: 'BEAT Pseudomonas: Beneficial bactEria AgainsT Pseudomonas'

Research towards novel therapies against chronic lung infections

The role of host-microbiome interactions in the efficacy of antimicrobial agents

Towards novel treatments against lung diseases.

Cystic fibrosis as a modulable model for host – microorganism interactions in airway disease.

Democratizing High-Throughput Next Generation Sequencing across different Life Science Fields: the AVITI Next Generation Sequencer.

Equipment for establishment of a three-dimensional tissue culture facility

Pathogenesis of lymphoid follicle formation and mucosal immunity in Chronic Obstructive Pulmonary Disease

White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imaging